Enhancing Diagnosis in Chronic B-cell Lymphoproliferative Disorders Using Next-Generation Sequencing

Active, not recruitingOBSERVATIONAL

Enrollment

127

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

April 30, 2023

Study Completion Date

May 31, 2026

Conditions

Lymphoma

Trial Locations (1)

The Royal Marsden NHS Foundation Trust, Sutton

All Listed Sponsors

lead

Royal Marsden NHS Foundation Trust

OTHER

NCT03344809 - Enhancing Diagnosis in Chronic B-cell Lymphoproliferative Disorders Using Next-Generation Sequencing | Biotech Hunter | Biotech Hunter